23 febrero 2015
In developing an orphan drug policy, Canada must ensure that all orphan drugs for rare diseases — both old and future drugs — should be priced fairly so that Canadians may access life-saving therapy, argue authors of a new Canadian analysis.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/5W8HCg9jlzM/150223142246.htm
